JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Biochemical Reagent
Signaling pathways

Signaling pathways

BA5857 CD80-IN-3

Summary: CD80-IN-3 is a potent inhibitor.
BA5858 Solitomab

Summary: Solitomab (AMG110) is a bispecific anti- and anti-epithelial cell adhesion molecule antibody.
BA5859 Muromonab

Summary: Muromonab is a monoclonal antibody that targets the receptor.
BA5860 Cibisatamab

Summary: Cibisatamab (CEA-TCB) is a T-cell bispecific antibody that binds to carcinoembryonic antigen on cancer cells and on T cells.
BA5861 Obrindatamab

Summary: Obrindatamab is a humanized anti-bispecific antibody.
BA5862 Pavurutamab

Summary: Pavurutamab (AMG-701) is a bispecific T-cell splicer molecule against and anti-B-cell maturation antigen.
BA5863 Pacanalotamab

Summary: Pacanalotamab (AMG420; BI-836909) is a bispecific T cell engager (BiTE).
BA5864 Pasotuxizumab

Summary: Pasotuxizumab (BAY2010112) is a bispecific T-cell engager (BiTE).
BA5865 Voxalatamab

Summary: Voxalatamab (JNJ-63898081) is a conjugateable bispecific antibody.
BA5866 Vibecotamab

Summary: Vibecotamab (XmAb14045) is a potent bispecific antibody that stimulates T cell-mediated targeted killing of CD123-expressing cells.